Publications

"We don't have the same bodies; we don't react the same way": mothers and adolescent girls' perceptions of the risks and benefits of HPV vaccination in France.

KARAFILLAKIS, E; Peretti-Watel, P; Verger, P; CHANTLER, T; LARSON, HJ;

2022

HUMAN VACCINES & IMMUNOTHERAPEUTICS, (2022).18 1 10.1080/21645515.2022.2036555.

Assessing the impacts of timing on the health benefits, cost-effectiveness and relative affordability of COVID-19 vaccination programmes in 27 African Countries.

LIU, Y; PEARSON, CA B; Madriz Montero, A; TORRES-RUEDA, S; Asfaw, E; Uzochukwu, B; Drake, T; Bergren, E; EGGO, R; RUIZ, F; Ndembi, N; Nonvignon, J; JIT, M; VASSALL, A;

2022

medRxiv (2022). 10.1101/2022.05.09.22274846.

Importance of ventilation and occupancy to Mycobacterium tuberculosis transmission rates in congregate settings.

Deol, AK; Shaikh, N; Middelkoop, K; Mohlamonyane, M; WHITE, RG; MCCREESH, N;

2022

BMC public health, (2022).22 1 10.1186/s12889-022-14133-5.

Comparative effectiveness of BNT162b2 versus mRNA-1273 boosting in England: a cohort study in OpenSAFELY-TPP.

Hulme, W; Horne, EM F; PARKER, EP K; KEOGH, R; WILLIAMSON, E; Walker, V; Palmer, T; Curtis, H; Walker, A; Mehrkar, A; Morley, J; MacKenna, B; Bacon, SC J; GOLDACRE, B; Hernán, M; Sterne, JA C; The OpenSAFELY collaborative,;

2022

medRxiv (2022). 10.1101/2022.07.29.22278186.

The potential cost-effectiveness of HPV vaccination among girls in Mongolia.

Luvsan, M-E; Vodicka, E; Jugder, U; Tudev, U; CLARK, A; Groman, D; Otgonbayar, D; Demberelsuren, S; LaMongtagne, DS; Pecenka, C;

2022

Vaccine: X, (2022).11, 10.1016/j.jvacx.2022.100161.

Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study.

Debellut, F; Pecenka, C; Hausdorff, WP; CLARK, A;

2022

Human vaccines & immunotherapeutics, (2022).18 1 10.1080/21645515.2022.2040329.

Live-attenuated influenza vaccine effectiveness against hospitalization in children aged 2-6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14-2015/16.

Boddington, NL; MANGTANI, P; Zhao, H; Verlander, NQ; Ellis, J; Andrews, N; Pebody, RG;

2022

Influenza and Other Respiratory Viruses, (2022).16 5 10.1111/irv.12990.

Emulation and History Matching using the hmer Package.

Iskauskas, A; Vernon, I; Goldstein, M; SCARPONI, D; McKinley, TJ; WHITE, RG; MCCREESH, N;

2022

(2022).

Adding to the mantra: vaccines prevent illness and death, and preserve existing antibiotics.

HEYMANN, DL; Kieny, M-P; Laxminarayan, R;

2022

The Lancet. Infectious diseases, (2022).22 8 10.1016/s1473-3099(22)00374-7.

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.

Feikin, DR; Higdon, MM; Abu-Raddad, LJ; Andrews, N; Araos, R; Goldberg, Y; Groome, MJ; Huppert, A; O'Brien, KL; SMITH, PG; WILDER-SMITH, A; Zeger, S; Deloria Knoll, M; Patel, MK;

2022

Lancet, (2022).399 10328 10.1016/S0140-6736(22)00152-0.